יחס שווי פעילות לרווח לפני ריבית, מסים ופחת Biolase Inc. (BIOL)

This BIOLASE, Inc. (BIOL) chart on GURU.Markets, where EV/EBITDA stands at , demonstrates the dental laser manufacturer's struggle for clinic budgets amid pressure from traditional methods. The business is suffering from operating losses, component shortages, and slow adoption of innovations by practitioners. Meanwhile, a stable cash flow is maintained through the servicing of previously sold systems and the sale of replacement nozzles.

The multiple compares the total enterprise value, including net debt, with operating profit before taxes and amortization to determine the asset's real value. By analyzing the EV/EBITDA value of the company on the chart, an investor identifies whether the business is overbought or undervalued relative to its ability to generate cash flow. For BIOLASE, Inc. (BIOL), this metric reflects the efficiency of capital investments in robotic laser systems that automate microsurgery in dentistry.